Abstract
During the development from stem cell to mature erythrocyte, the human red cell loses several of its metabolic and synthetic capacities. The mature red cell is devoid of DNA and RNA and therefore lacks the possibility of protein synthesis. With respect to metabolism, the disappearance of mitochondria and ribosomes deprives the erythroid cell from obtaining energy through oxydative phosphorylation and from renewed enzyme required in metabolic processes. As a consequence the mature red cell is almost completely dependent upon anaerobic glycolysis as a source of energy supply during its 120 day mean life span. Despite the limited metabolic capacity of the glycolytic pathway in the mature erythrocyte sufficient ATP is available for processes involved in its optimal functioning i.e. keeping the haem iron in the reduced state, synthesis of glutathione, maintaining the electrochemical gradients over the plasma membrane, salvage of purine nucleotides and protection of hemoglobin against methemoglobin formation and oxidative denaturation. In reticulocytes the energy consumption pattern is completely different. First of all the production of ATP is about 100 times higher than in mature erythrocytes, partly by increased glycolytic enzyme activities and further by a still intact oxidative phosphorylation. The increased activities of glycolytic enzymes in young red cell fractions predominantly concern those of hexokinase, pyruvate kinase and glucose-6-phosphate dehydrogenase. The increased enzyme activities are linearly correlated with the reticulocyte counts in these fractions. This finding suggests that the presumed age dependency of these enzymes is mainly related to reticulocyte maturation. In patients with hemolytic anemia the diagnosis of a deficiency of one of these enzymes may be masked by an increased reticulocyte number. On the other hand in patients with severe transfusiondependent hemolytic anemia, the diagnosis of an erythrocyte enzymopathy is often troubled by the presence of relatively large amounts of donor erythrocytes with normal enzyme activities. In this paper we present a few examples, mainly concerning abnormal pyruvate kinase, illustrating the above mentioned problems, in the diagnosis of an enzymopathy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
H. Chr. Benöhr, and H. D. Waller, Metabolism in hemolytic states, Clin. Haematol., 4:45 (1975).
G. Rijksen, J.-W. N. Akkerman, A. W. L. van den Wall, D. Pott hofstede, and G. E. J. Staal, Generalized Hexokinase deficiency in the blood cells of a patient with non-spherocytic hemolytic anemia, Blood, 61:12 (1983).
G. E. J. Staal and G. Rijksen, Regulation of pyruvate kinase in normal and pathological conditions, in “Regulation of Carbohydrate metabolism”, R. Beitner, ed., vol. 1:143, CRC Press, Boca Raton (1985).
K. Imamura, K. Taniuchi and T. Tanaka. Multimolecular forms of pyruvate kinase, J. Biochem. 71:1001 (1972).
G. E. J. Staal, G. Rijksen, A. M. C. Vlug, B. Vromen-van den Bos, J.-W. N. Akkerman, G. Gorter, J. Dierick and M. Petermans. Extreme deficiency of L-type pyruvate kinase with moderate clinical expression, Clin. Chim. Acta 118:241 (1982).
J. Marie, M. P. Simon, J. C. Dreyfus and A. Kahn, One gene, but two messenger RNAs encode liver L and red Cell L’ pyruvate kinase subunits, Nature 292:70 (1981).
M. Cognet, Y. C. Lone, S. Vaulont, A. Kahn and J. Marie, Structure of the rat L-type pyruvate kinase gene, J. Mol. Biol. 196:11 (1987).
G. L. Tremp, J. Boquet, A. Kahn and D. Doegelen, Expression of the rat L-type pyruvate kinase gene from its dual erythroid and liver specific promoter in transgene mice, J. Biol. Chem. 264:19904 (1989).
T. Noguchi, H. Inone and T. Tanaka, The M-and M-types isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing, J. Biol. Chem. 261:13807 (1986).
G. Rijksen, A. J. P. Veerman, G.P.M. Schipper-kester and G. E. J. Staal, Diagnosis of pyruvate kinase deficiency in a transfusion dependent patient with severe hemolytic anemia, American J. of Hematology (1990) in press.
C. M. Rennie, S. Thompson, A. C. Parker, A. Maddy, Human erythrocyte fraction in “Percoll” density gradients, Clin. Chim. Acta 98:119 (1979).
H. E. van Erp, P. J. M. Roholl, E.D. Sprengers, C. W. M. van Veelen, G.E. J. Staal, Production and characteriztion of monoclonal antibodies against human L-type pyruvate kinase, Eur. J. Cell Biol. 47:388 (1988).
G. E. J. Staal, G. Jansen and D. Roos, Pyruvate kinase and the “High ATP syndrome”, J. Clin.Invest. 74:231 (1984).
G. E. J. Staal, J. F. Koster, H. Hamp, L. Van Milligen-Boersma and C. Veeger, Human erythrocyte pyruvate kinase. Its purification and some properties. Biochim. Biophys. Acta 227:86 (1971).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Staal, G.E.J., Rijksen, G. (1991). The Role of Red Cell Aging in the Diagnosis of Glycolytic Enzyme Defects. In: Magnani, M., De Flora, A. (eds) Red Blood Cell Aging. Advances in Experimental Medicine and Biology, vol 307. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5985-2_22
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5985-2_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5987-6
Online ISBN: 978-1-4684-5985-2
eBook Packages: Springer Book Archive